Primary Site >> Colorectal Cancer
Gene >> VEGFB
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Vegf, Vegf-B, Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa. PMID: 10738243 |
Ref: The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. PMID: 12754739 Ref: Expression analysis of vascular endothelial growth factors and their relationships to lymph node metastasis in human colorectal cancer. PMID: 12866573 |
Ref: (86)Y-CHX-A''-Diethylenetriamine pentaacetic acid-bevacizumab PMID: 21433411 Ref: (64)Cu-1,4,7-Triazacyclononane-1,4,7-triacetic acid-p-isothiocyanatobenzyl-bevacizumab-IRDye 800CW PMID: 23534080 |
Ref: Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells. PMID: 15735759 |
Ref: Regulation of vascular endothelial growth factor receptor-1 expression by specificity proteins 1, 3, and 4 in pancreatic cancer cells. PMID: 17409437 |
Ref: Impact of angiogenesis-related gene expression on the tracer kinetics of 18F-FDG in colorectal tumors. PMID: 18632818 |
Ref: Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer. PMID: 20222950 Ref: Anti-proliferative and anti-cancer properties of Achyranthes aspera: specific inhibitory activity against pancreatic cancer cells. PMID: 20541002 Ref: Increased angiogenesis in Cdk4(R24C/R24C):Apc(+/Min) intestinal tumors. PMID: 20603602 |
Ref: Clinical procedure for colon carcinoma tissue sampling directly affects the cancer marker-capacity of VEGF family members. PMID: 23148666 |
Ref: Salutary effects of adiponectin on colon cancer: in vivo and in vitro studies in mice. PMID: 22735569 Ref: Targeted therapy for metastatic colorectal cancer: role of aflibercept. PMID: 23102896 Ref: VEGF-B expression in colorectal carcinomas and its relevance for tumor progression. PMID: 23417498 Ref: Adverse events associated with antiangiogenic agents in combination with cytotoxic chemotherapy in metastatic colorectal cancer and their management. PMID: 23562587 Ref: Identification of candidate oncogenes in human colorectal cancers with microsatellite instability. PMID: 23684749 |
Ref: Differential antitumor activity of aflibercept and bevacizumab in patient-derived xenograft models of colorectal cancer. PMID: 24688047 |
Ref: Chronic exposure of VEGF inhibitors promotes the malignant phenotype of colorectal cancer cells. PMID: 25817288 Ref: Cell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis. PMID: 25880726 Ref: Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer. PMID: 26125443 |
Ref: Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study. PMID: 29636300 Ref: Association Between Hypoxia-Inducible Factor-2alpha (HIF-2alpha) Expression and Colorectal Cancer and Its Prognostic Role: a Systematic Analysis. PMID: 30021192 |